Reprogrammed endothelial cells: Cell therapy for coronary collateral growth?

Circulation Research

Volumn 110, Issue 2, 2012, Pages 192-194

  Faber, James E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

collateral circulation; coronary circulation; ischemia; progenitor cells

Indexed keywords

CD133 ANTIGEN; KRUPPEL LIKE FACTOR 4; MEMBRANE PROTEIN; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN AP; PROTEIN REX1; REX PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 1; STEM CELL FACTOR; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL HOMING; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLLATERAL CIRCULATION; DNA METHYLATION; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EPIGENETICS; FIBROBLAST; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; MESENCHYMAL STEM CELL; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIUM;

ANIMALS; COLLATERAL CIRCULATION; CORONARY CIRCULATION; CORONARY OCCLUSION; CORONARY VESSELS; ENDOTHELIAL CELLS; INDUCED PLURIPOTENT STEM CELLS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE;

EID: 84856038748     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.111.261495     Document Type: Editorial

References (27)

1. Faber JE, Dai X, Lucitti J. Genetic and environmental mechanisms controlling formation and maintenance of the native collateral circulation. In: Deindl E, Schaper W, eds. Arteriogenesis-Molecular Regulation, Pathophysiology and Therapeutics. Shaker Verlag; 2011:1-22.
2. Faber JE, Zhang H, Lassance-Soares RM, Prabhakar P, Najafi AH, Burnett MS, et al. Aging causes collateral rarefaction and increased severity of ischemic injury in multiple tissues. Arterioscler Thromb Vasc Biol. 2011;31:1748-1756.
3. Wang S, Zhang H, Dai X, Sealock R, Faber JE. Genetic architecture underlying variation in extent and remodeling of the collateral circulation. Circulation Res. 2010;107:558-568.
4. Schaper W. Collateral circulation: Past and present. Basic Res Cardiol. 2009;104:5-21.
5. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, Zbinden S, Wustmann K, Billinger M, Vogel R, Cook S, Wenaweser P, Togni M, Windecker S, Meier B, Seiler C. Beneficial effect of recruitable collaterals: A 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation. 2007;116:975-983. (Pubitemid 47329562)
6. Menon BK, Smith EE, Modi J, Patel SK, Bhatia R, Watson TW, Hill MD, Demchuk AM, Goyal M. Regional leptomeningeal score on CT angiography predicts clinical and imaging outcomes in patients with acute anterior circulation occlusions. Am J Neuroradiol. 2011;32:1640-1645.
7. Beohar N, Rapp J, Pandya S, Losordo DW. Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Cardiol. 2010;56:1287-1297.
8. Schirmer SH, van Nooijen FC, Piek JJ, van Royen N. Stimulation of collateral artery growth: travelling further down the road to clinical application. Heart. 2009;95:191-197.
9. Tirziu D, Simons M. Angiogenesis in the human heart: gene and cell therapy. Angiogenesis. 2005;8:241-251. (Pubitemid 41759149)
10. Leri A, Kajstura J, Anversa P. Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res. 2011;109:941-961.
11. Madonna R, Rokosh G, De Caterina R, Bolli R. Hepatocyte growth factor/Met gene transfer in cardiac stem cells-potential for cardiac repair. Basic Res Cardiol. 2010;105:443-452.
12. Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011;109:923-940.
13. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-676. (Pubitemid 44233629)
14. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313-317. (Pubitemid 47080336)
15. Okita K, Yamanaka S. Induced pluripotent stem cells: Opportunities and challenges. Phil Trans R Soc London Series B Biol Sci. 2011;366: 2198-2207.
16. Kaichi S, Hasegawa K, Takaya T, Yokoo N, Mima T, Kawamura T, Morimoto T, Ono K, Baba S, Doi H, Yamanaka S, Nakahata T, Heike T. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. Cardiovasc Res. 2010;88:314-323.
17. Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S, Yamanaka S, Yamashita JK. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation. 2008;118:498-506.
18. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008;322:949-953.
19. Iacobas I, Vats A, Hirschi KK. Vascular potential of human pluripotent stem cells. Arterioscler Thromb Vasc Biol. 2010;30:1110-1117.
20. Menendez S, Camus S, Herreria A, Paramonov I, Morera LB, Collado M, Pekarik V, Maceda I, Edel M, Consiglio A, Sanchez A, Li H, Serrano M, Belmonte JC. Increased dosage of tumor suppressors limits the tumorigenicity of ips cells without affecting their pluripotency. Aging Cell. 2011 Oct 10 [Epub ahead of print].
21. Yin L, Ohanyan V, Fen Pung Y, Delucia A, Bailey E, Enrick M, Stevanov K, Kolz CL, Guarini G, Chilian WM. Induction of vascular progenitor cells from endothelial cells stimulates coronary collateral growth. Circ Res. 2012;110:241-252.
22. Dai X, Faber JE. Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis. Circ Res. 2010;106:1870-1881.
23. Kinnaird T, Stabile E, Zbinden S, Burnett MS, Epstein SE. Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions. Cardiovasc Res. 2008;78:257-264. (Pubitemid 351556098)
24. Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler Thromb Vasc Biol. 2006;26:257-266. (Pubitemid 43732183)
25. Templin C, Lüscher TF, Landmesser U. Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments. Int J Dev Biol. 2011;55:407-417.
26. Buschmann EE, Utz W, Pagonas N, Schulz-Menger J, Busjahn A, Monti J, Maerz W, le Noble F, Thierfelder L, Dietz R, Klauss V, Gross M, Buschmann IR. Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.-2 Trial). Eur J Clin Invest. 2009;39:866-875.
27. Vogel R, Traupe T, Steiger VS, Seiler C. Physical coronary arteriogenesis: a human "model" of collateral growth promotion. Trends Cardiovasc Med. 2010;20:129-133.